These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2498778)

  • 21. Cyclosporine and familial Mediterranean fever amyloidosis.
    Siegal B; Zemer D; Pras M
    Transplantation; 1986 Jun; 41(6):793-4. PubMed ID: 3520994
    [No Abstract]   [Full Text] [Related]  

  • 22. [Patient with familial Mediterranean fever and amyloidosis].
    Atanasova P
    Vutr Boles; 1985; 24(5):93-6. PubMed ID: 4090459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From familial Mediterranean fever to amyloidosis].
    Vinceneux P; Pouchot J
    Presse Med; 2005 Jul; 34(13):958-66. PubMed ID: 16142155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic familial Mediterranean fever with development of secondary amyloidosis.
    Larrimore C
    Clin Lab Sci; 2011; 24(1):2-7. PubMed ID: 21404957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of colchicine on the amyloidosis of familial Mediterranean fever].
    Zemer D; Sohar E; Pras M; Cabili S; Gafni J
    Harefuah; 1985 Jan; 108(1):1-2. PubMed ID: 3996948
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic approach to patients with familial Mediterranean fever-related amyloidosis resistant to colchicine.
    Korkmaz C
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S104-7. PubMed ID: 23010471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The kidney in familial Mediterranean fever.
    Zemer D; Livneh A; Pras M; Sohar E
    Contrib Nephrol; 1993; 102():187-97. PubMed ID: 8416182
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
    Ugurlu S; Ergezen B; Egeli BH; Selvi O; Ozdogan H
    Rheumatology (Oxford); 2020 Dec; 59(12):3892-3899. PubMed ID: 32556219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever.
    Yüksel S; Yalçinkaya F; Acar B; Ozçakar ZB; Oztürk B; Ekim M
    Rheumatology (Oxford); 2006 Oct; 45(10):1307-8. PubMed ID: 16880190
    [No Abstract]   [Full Text] [Related]  

  • 30. Familial Mediterranean fever: no association of HLA with amyloidosis or colchicine treatment response.
    Fradkin A; Pras M; Zemer D; Gazit E
    Isr J Med Sci; 1985 Sep; 21(9):757-8. PubMed ID: 4055337
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.
    Ben-Zvi I; Danilesko I; Yahalom G; Kukuy O; Rahamimov R; Livneh A; Kivity S
    Isr Med Assoc J; 2012 Apr; 14(4):221-4. PubMed ID: 22675837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine toxicity in amyloidotic patients.
    Siegal B; Zemer D; Shtrasburgh S; Pras M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1544-5. PubMed ID: 3274378
    [No Abstract]   [Full Text] [Related]  

  • 33. [Toxic myopathy with kidney failure as a colchicine side effect ifn familial Mediterranean fever].
    Stefanidis I; Böhm R; Hägel J; Maurin N
    Dtsch Med Wochenschr; 1992 Aug; 117(33):1237-40. PubMed ID: 1499522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term colchicine therapy for renal amyloidosis in familial Mediterranean fever.
    Walker F; Bear RA
    Can Med Assoc J; 1982 Dec; 127(12):1163-4. PubMed ID: 7139463
    [No Abstract]   [Full Text] [Related]  

  • 35. Colchicine in amyloidosis.
    Lancet; 1986 Sep; 2(8509):724-5. PubMed ID: 2876192
    [No Abstract]   [Full Text] [Related]  

  • 36. A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report.
    Saglam F; Celik A; Cavdar C; Sifil A; Atila K; Kaya GC; Bora S; Gulay H; Camsari T
    Transplant Proc; 2008; 40(1):308-9. PubMed ID: 18261613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fever of unknown origin and colchicine-sensitive amyloidosis: familial Mediterranean fever?].
    Schneider W; Wehmeier A
    Dtsch Med Wochenschr; 1989 Jun; 114(24):951-4. PubMed ID: 2731480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systemic AA amyloidosis caused by familial Mediterranean fever and response to colchicine].
    Fukui N; Mukoyama M; Saito Y; Mori K; Kasahara M; Yokoi H; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nihon Naika Gakkai Zasshi; 2008 Dec; 97(12):3046-8. PubMed ID: 19209520
    [No Abstract]   [Full Text] [Related]  

  • 39. Regression of amyloidosis with colchicine in familial Mediterranean fever in an Ashkenazi patient.
    Rozenbaum M; Rosner I
    Clin Exp Rheumatol; 1995; 13(1):126. PubMed ID: 7774093
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal transplantation in the amyloidosis of familial Mediterranean fever. Experience in ten cases.
    Jacob ET; Bar-Nathan N; Shapira Z; Gafni J
    Arch Intern Med; 1979 Oct; 139(10):1135-8. PubMed ID: 384952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.